Ernst Lengyel to Neoadjuvant Therapy
This is a "connection" page, showing publications Ernst Lengyel has written about Neoadjuvant Therapy.
Connection Strength
0.644
-
Neoadjuvant Chemotherapy Induces Genomic and Transcriptomic Changes in Ovarian Cancer. Cancer Res. 2022 01 01; 82(1):169-176.
Score: 0.556
-
Adaptive immune response and PD-1/ PD-L1 status in chemotherapy treated high grade serous carcinoma is dependent on chemotherapy response score. Hum Pathol. 2025 May; 159:105800.
Score: 0.044
-
Metformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial. Gynecol Oncol. 2025 Mar; 194:18-24.
Score: 0.044